Segments - Medical Decision Support Systems for Sepsis Market by Type (Type I and Type II),Deployment Model (Cloud-based and On-premises), Application (Diagnostic Center and Hospital), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size,Trends, and Forecast 2023 – 2031
The global Medical Decision Support Systems for Sepsis market size was USD 35.2 Mn in 2022 and is likely to reach USD 247.5 Mn by 2031, expanding at a CAGR of 24.2 % during 2023–2031. The market growth is attributed to the increasing awareness among healthcare professionals regarding the benefits of a decision-support system.
Rising prevalence of sepsis is anticipated to significantly boost the growth of the medical decision support systems for sepsis market in the coming years.Growing technological advancements enable real-time data integration, support in clinical decision-making, and pattern recognition leading to improved sepsis management.
A Medical Decision Support System (MDSS) for sepsis is a specialized software or tool designed to assist healthcare providers in diagnosing and managing sepsis effectively. It integrates clinical data from various sources such as electronic health records (EHRs), laboratory results, vital signs, and patient history to provide timely and relevant information to aid in clinical decision-making.
The market report finds that the COVID-19 pandemic boosted the medical decision support system for sepsis market. The pandemic has highlighted the importance of early detection and effective management of critical illnesses, including sepsis. This led to an increased focus on technologies such as MDSS that aid healthcare providers in making timely and accurate decisions for septic patients.
Artificial Intelligence(AI) is expected to boost the revenue of the market players present in the medical decision support systems for sepsis market. AI and machine learning (ML) algorithms analyze vast amounts of patient data to assist healthcare providers in making accurate decisions for septic patients on time. AI-driven MDSS recognizes subtle indicators of sepsis that are missed by human clinicians. This enables early intervention, which leads to improved outcomes and patient care.
Increasing pressure to reduce healthcare spending while simultaneously improving patient outcomes drives the market. MDSS helps healthcare providers to make precise and timely decisions for septic patients. This leads to efficient use of resources, including medications, tests, and medical personnel that ultimately reduces unnecessary expenses.Timely and effective sepsis management through MDSS leads to short hospital stays. This reduces costs associated with prolonged hospitalization and also opens up bed capacity for other patients.
Rising concerns related to unreliable and conflicting data hampers the market. Incorrect or outdated data put in the MDSS leads to incorrect recommendations for sepsis management. This potentially harms patients and destroys trust in the system. Human error in data entry introduces inaccuracies into the MDSS such as typos or incorrect entries that lead to incorrect patient assessments.
Growing research grants and funding creates lucrative opportunities for the market.Research grants and funding provide financial support to institutions and companies working on developing and improving MDSS technologies. This encourages the innovation of advanced and effective systems for sepsis management. Increasing the availability of additional resources, developers are able to invest in advanced technologies such as artificial intelligence, machine learning, and data analytics to enhance the capabilities of MDSS for sepsis.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Medical Decision Support Systems for Sepsis Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Type (Type I and Type II),Deployment Model (Cloud-based and On-premises), and Application (Diagnostic Centerand Hospital) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, MarketTrends, and Revenue Forecast |
Key Players Covered in the Report |
Ambient Clinical Analytics; Health Catalyst.; Koninklijke Philips N.V.; Iatric Systems Inc.; MCKESSON CORPORATION; Oracle; Priority Digital Health Ltd.; Veradigm LLC; and Wolters Kluwer N.V. |
Based on type, the medical decision support systems for sepsis market is divided into type I and type II. The type I segment is expected to hold a dominant share of the market during the projection period,as it provides early intervention and real-time data analysis.
Type I MDSS systems are designed to provide alerts and recommendations that are based on specific clinical criteria and thresholds. This early warning system is crucial for sepsis management, as it allows for timely intervention that is vital in improving patient outcomes. Type I MDSS continuously monitors patient data in real time, which allows for generating immediate analysis and alert. This is particularly important in sepsis cases where rapid assessment and intervention are life-saving.
On the basis of deployment model, the global market is segregated into cloud-based and on-premises. The on-premises segmentis projected to register a high CAGR during the forecast period,as it provides data security.
Healthcare organizations, especially those dealing with sensitive patient data, have strict regulations or policies that require them to maintain control over their data. On-premises solutions allow them to have direct oversight and control of their data, reducing concerns about data breaches or unauthorized access.
The cloud-based segment is expected to expand at a significant growth rate in the coming years, as it provides remote accessibility and rapid development. Cloud-based systems are accessed from anywhere with an internet connection. This is particularly beneficial for healthcare providers who need to access patient information remotely or collaborate with colleagues in different locations. Implementing a cloud-based solution is typically faster than deploying an on-premises system. This is crucial in healthcare, where quick access to critical information makes a significant difference in patient outcomes.
On the basis of application, the medical decision support systems for sepsis market is segmented into diagnostic center and hospital. The hospital segment is anticipated to register a robust growth rate during the forecast period, as it provides critical care to patients and has a high volume of patient visits.
Hospitals, especially those equipped with intensive care units (ICUs), are the primary settings for managing septic patients. Sepsis is a time-sensitive condition, and hospitals play a pivotal role in early detection & intervention. Hospitals typically handle a large volume of patients, including those at risk of sepsis. This high patient volume highlights the need for robust medical decision support systems (MDSS) to assist healthcare providers in making accurate decisions.
The diagnostic center segment is anticipated to gain significant revenue shares in the market, due to the increasing need for the presence of specialized expertise in diagnostics, efficient testing, and evaluation.
Diagnostic centers are specialized facilities equipped with advanced diagnostic tools and technologies. They have a strong focus on accurate and timely disease detection, making them crucial in sepsis diagnosis. Diagnostic centers are designed to efficiently conduct a wide range of diagnostic tests. This includes blood cultures, complete blood counts, biomarker as says, and other tests relevant to sepsis diagnosis.These centers provide rapid results that play a vital for the early detection of sepsis.
In terms of region, the global medical decision support systems for sepsis market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the global market during the projection period,due to advanced healthcare infrastructure and a strong emphasis on technological innovation.
North America is known for advanced and sophisticated healthcare infrastructures globally. This includes highly developed HER systems, well-established healthcare IT networks, and extensive diagnostic capabilities, all of which are conducive to the implementation and utilization of MDSS for sepsis.The region has embraced technological advancements in healthcare, including AI, machine learning, and data analytics that are integral components of MDSS.
The market in Asia Pacific is projected to expandrapidly during the forecast period, owing to the rapidly growing healthcare industry and high disease burden.The emerging economies in Asia Pacific are making significant investments in healthcare infrastructure, leading to increased adoption of advanced technologies such as MDSS.Asia Pacific is known for its growingpopulation.The region faces a substantial disease burden,including sepsis, with such a large population. This high prevalence of the disease drives the demand for effective sepsis management solutions such as MDSS across Asia Pacific.
The medical decision support systems for sepsis market has been segmented on the basis of
Key players competing in the global medical decision support systems for sepsis market areAmbient Clinical Analytics; Health Catalyst.; Koninklijke Philips N.V.; Iatric Systems Inc.; MCKESSON CORPORATION; Oracle; Priority Digital Health Ltd.; Veradigm LLC; and Wolters Kluwer N.V.
These companies adopted development strategies, including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion, to expand their consumer base across the globe. For instance,
In September 2023,Veradigm, a key provider of healthcare data and technology solutions,collaborated with On Belay Health Solutions to expand value-based care solutions for strengthening primary care practice and improving patient health outcomes.